Force Oxygen | Micro‑pressure oxygen therapy nurtures liver health, and CEO‑1 helps you embark on the path to wellness.

Liver disease is a major challenge for many patients. As modern lifestyles evolve, liver health is increasingly under threat. Many people unwittingly create hidden health risks, yet when illness strikes, suffering becomes unavoidable. Fortunately, we live in an era of rapid technological advancement, and hyperbaric oxygen therapy has emerged as an effective approach for both preventing and alleviating liver disease.

Mechanism of Hyperbaric Oxygen Therapy in Alleviating Liver Disease

For patients already diagnosed with liver disease, hyperbaric oxygen therapy also provides significant symptomatic relief. High‑concentration oxygen increases the oxygen content in the blood, enhances the uptake of oxygen molecules throughout the body, effectively alleviates hepatic hypoxia, and reduces patient discomfort. Moreover, hyperbaric oxygen therapy helps lower systemic inflammation, relieve pain and discomfort associated with liver disease, and improve the patient’s quality of life.

The preventive effects of hyperbaric oxygen therapy on liver diseases

Hyperbaric oxygen therapy improves the partial pressure of oxygen in the body by delivering high-concentration oxygen, It helps promote blood circulation and enhance the liver’s oxygenation capacity. 。 This not only helps reduce the burden on the liver but also promotes the regeneration and repair of hepatocytes, thereby enhancing hepatic metabolic function. Some studies have shown that hyperbaric oxygen therapy can also suppress the development of hepatic inflammation, thereby effectively preventing liver disease. Development.

Case of Improvements in Acute Hepatitis Treated with Hyperbaric Oxygen Therapy

Severe hepatitis is an infectious disease caused by hepatitis A virus, hepatitis B virus, or mixed infections, with hepatic cellular degeneration and necrosis as its primary pathological features. The condition is severe and associated with a high mortality rate, making early diagnosis and prompt treatment of paramount importance. At present, there is no definitively effective specific therapy; therefore, the development of novel therapeutic strategies is urgently needed. Research indicates that hyperbaric oxygen therapy has emerged as a novel treatment for severe hepatitis, and clinical observations have demonstrated its significant therapeutic benefits in cases of acute hepatitis.

In this clinical trial, we randomly assigned participants to a treatment group and a control group, with 40 cases in each group. The treatment group comprised 31 males and 9 females, aged between 35 and 63 years. The control group comprised 33 males and 7 females, with ages ranging from 33 to 65 years. The comparison of baseline characteristics between the two patient groups revealed no statistically significant differences (P > 0.05), thereby ensuring comparability.

In terms of treatment methods, the treatment group The experimental group received a combination of hyperbaric oxygen therapy and comprehensive treatment, whereas the control group received only comprehensive treatment. Hyperbaric oxygen therapy employs Hyperbaric oxygen therapy in a single-person chamber is administered at a pressure of 0.25 MPa, once daily for 2 hours per session. Comprehensive therapy encompasses antiviral treatment, immunomodulation, promotion of hepatocyte proliferation, hepatoprotection, and nutritional support. Each treatment course lasts 10 days, and patients in both groups received three courses of therapy.

Based on observations from clinical trials and data analysis, It was found that, in the treatment group, the combination of hyperbaric oxygen therapy and comprehensive treatment significantly improved the condition of patients with hepatitis. This comprehensive therapeutic strategy helps accelerate patient recovery and offers an effective new approach to the treatment of hepatitis.

Force Oxygen CEO-1: Safeguarding Your Liver

The Force Oxygen high-end home‑use smart oxygen chamber, model CEO‑1, developed by the Osenpal team, rapidly increases blood oxygen saturation, partial pressure of oxygen, and the diffusion distance of oxygen in the bloodstream, thereby stimulating cellular aerobic metabolism. This effectively alleviates symptoms of tissue and organ hypoxia, improves systemic microcirculation and hepatic microcirculatory dysfunction, and promotes liver function recovery while ameliorating related symptoms.

Force Oxygen is a wellness‑focused product brand under Guangzhou Aoshenpal Life Science Technology Co., Ltd., specializing in residential hyperbaric oxygen chambers that integrate spacecraft‑grade pressure‑balancing technology, nanomaterials, and patented oxygen‑generation systems. The CEO-1 features efficient air purification, removal of fine particulates and pollutants, deodorization, and freshness‑preserving functions, along with one‑button power off, emergency pressure relief, and fire‑retardant safety protection. 。

After several 60-minute sessions of mild hyperbaric oxygen therapy, symptoms of mild hypoxia have improved markedly. With every breath, your body’s cells are nourished. Daily oxygen therapy for 60 to 90 minutes boosts immunity, combats aging, accelerates wound healing, and helps prevent chronic conditions such as cardiovascular and cerebrovascular diseases. Mild hyperbaric oxygen therapy also enhances cerebral metabolism, restores brain function, and offers preventive benefits for liver health. Let us join forces and, through mild hyperbaric oxygen therapy, move together toward a healthy, worry-free future!